Modulation of the TLR4-Lyn interaction in SAH

SAH 中 TLR4-Lyn 相互作用的调节

基本信息

  • 批准号:
    10844778
  • 负责人:
  • 金额:
    $ 36.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Hemorrhagic stroke affects 160,000 Americans per year and over half of these patients will die by the end of the year. Treatment for both forms of hemorrhagic stroke, intraparenchymal hemorrhage and aneurysmal subarachnoid hemorrhage, have been at a virtual standstill for the last 40 years, and not due to lack of effort. Perhaps the reason for the lack of progress is an inability to effectively address the cerebral inflammation secondary to the extravasated red blood cell (RBC) burden. In animal models of hemorrhagic stroke, microglia (MG), the tissue resident macrophages of the brain, have been shown to play a critical role in RBC-induced cerebral inflammation. The MG receptor that is responsible for initiating RBC-induced cerebral inflammation is Toll Like Receptor 4 (TLR4). In mouse models of hemorrhagic stroke, MG TLR4 responds to the breakdown products of RBCs to initiate cerebral inflammation. While inhibiting MG TLR4 would seem feasible to prevent cerebral inflammation in hemorrhagic stroke, this strategy carries a significant risk of immunosuppression. Modulation of non-canonical TLR4 pathways that are downstream of TLR4 may offer some respite against MG-mediated cerebral inflammation. Lyn kinase (Lyn) is a Src-family tyrosine kinase expressed by B, myeloid, and dendritic cells. Lyn is unique in the SFK family in that it has both stimulatory and feedback-inhibitory pathways in B cell receptor signaling that can lead to ligand tolerance. Evidence for Lyn kinase regulation of TLR4 signaling in response to bacterial PAMPs is scant, contradictory, and cell type dependent. Understanding Lyn regulation of TLR4 signaling in response to an RBC stimulus in MG is novel, and could allow for the modulation of cerebral inflammation in hemorrhagic stroke. Our lab has found that MG TLR4-Lyn signaling is important for RBC-induced inflammation and RBC phagocytosis. Our preliminary data indicates that modulation of this pathway does indeed decrease neuronal apoptosis, in vitro. We hypothesize that modulation of this pathway in MG can improve outcome after SAH and possibly other forms of hemorrhagic stroke.
出血性中风每年影响160,000美国人,这些患者中有一半以上将在年底前死亡。 当年两种形式的出血性卒中(脑实质内出血和脑出血)的治疗 蛛网膜下腔出血,在过去的40年里一直处于实质上的停滞状态,而不是因为缺乏努力。 也许缺乏进展的原因是无法有效地解决大脑炎症 继发于外渗的红细胞(RBC)负荷。在出血性中风的动物模型中, (MG)脑组织中的巨噬细胞,已被证明在RBC诱导的 脑炎症负责启动RBC诱导的脑炎症的MG受体是 Toll样受体4(TLR 4)。在出血性中风的小鼠模型中,MG TLR 4响应于 红细胞的产物引发大脑炎症。虽然抑制MG TLR 4似乎是可行的, 在出血性中风的脑炎症中,这种策略具有显著的免疫抑制风险。 调节TLR 4下游的非经典TLR 4途径可能会缓解TLR 4的作用。 MG介导的脑炎症。 林恩激酶(林恩)是由B、髓样和树突细胞表达的Src家族酪氨酸激酶。林恩是独一无二的, SFK家族,因为它在B细胞受体信号传导中具有刺激和反馈抑制途径, 会导致配体耐受林恩激酶调节TLR 4信号转导应答细菌感染的证据 PAMPs是缺乏的、矛盾的和依赖于细胞类型的。了解林恩对TLR 4信号传导的调节, MG患者对RBC刺激的反应是新颖的,并且可以允许MG患者脑炎症的调节。 出血性中风 我们的实验室已经发现MG TLR 4-林恩信号传导对于RBC诱导的炎症和RBC诱导的炎症是重要的。 吞噬作用我们的初步数据表明,调节这一途径确实会减少神经元的 细胞凋亡,体外。我们假设MG中该通路的调节可以改善SAH后的结果, 可能是其他形式的出血性中风

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Post-stroke recrudescence-a possible connection to autoimmunity?
  • DOI:
    10.1515/revneuro-2021-0062
  • 发表时间:
    2021-08-06
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Akamatsu,Yosuke;Chaitin,Hersh J.;Hanafy,Khalid A.
  • 通讯作者:
    Hanafy,Khalid A.
Effects of Volatile Anesthetics on Postoperative Ischemic Stroke Incidence.
  • DOI:
    10.1161/jaha.120.018952
  • 发表时间:
    2021-03
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Raub D;Platzbecker K;Grabitz SD;Xu X;Wongtangman K;Pham SB;Murugappan KR;Hanafy KA;Nozari A;Houle TT;Kendale SM;Eikermann M
  • 通讯作者:
    Eikermann M
Development of a 3D Brain Model to Study Sex-Specific Neuroinflammation After Hemorrhagic Stroke.
开发 3D 大脑模型来研究出血性中风后性别特异性神经炎症。
  • DOI:
    10.1007/s12975-024-01243-y
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    6.9
  • 作者:
    Islam,Rezwanul;Choudhary,HadiHasan;Mehta,Hritik;Zhang,Feng;Jovin,TudorG;Hanafy,KhalidA
  • 通讯作者:
    Hanafy,KhalidA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Khalid A. Hanafy其他文献

TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential
  • DOI:
    10.1007/s12035-024-04518-5
  • 发表时间:
    2024-09-28
  • 期刊:
  • 影响因子:
    4.300
  • 作者:
    Feng Zhang;Hritik Mehta;Hadi Hasan Choudhary;Rezwanul Islam;Khalid A. Hanafy
  • 通讯作者:
    Khalid A. Hanafy
We can Still Learn from a Negative Study
  • DOI:
    10.1007/s12028-023-01807-0
  • 发表时间:
    2023-08-03
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Khalid A. Hanafy
  • 通讯作者:
    Khalid A. Hanafy
Robotically assisted transcranial Doppler with artificial intelligence for assessment of cerebral vasospasm after subarachnoid hemorrhage
机器人辅助人工智能经颅多普勒评估蛛网膜下腔出血后脑血管痉挛
  • DOI:
    10.18700/jnc.200002
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shooka Esmaeeli;Courtney M. Hrdlicka;Andres Brenes Bastos;Jeffrey Wang;S. Gomez;Khalid A. Hanafy;V. Lioutas;C. Ogilvy;A. Thomas;S. Shaefi;C. Fehnel;A. Nozari
  • 通讯作者:
    A. Nozari
The doctor-patient perception mismatch: Improving approaches to assessing outcomes after ischemic stroke treated with reperfusion therapy
  • DOI:
    10.1016/j.jocn.2024.110981
  • 发表时间:
    2025-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Jane Khalife;Mary Penckofer;Michael J. Dubinski;Danielle C. Brown;Kenyon Sprankle;Taryn Hester;Marta Olive Gadea;Federica Rizzo;Marc Ribo;H.Christian Schumacher;Jesse M. Thon;Tudor G. Jovin;Manisha Koneru;Khalid A. Hanafy
  • 通讯作者:
    Khalid A. Hanafy
Cell Death and Recovery in Traumatic Brain Injury
  • DOI:
    10.1007/s13311-020-00840-7
  • 发表时间:
    2020-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Yosuke Akamatsu;Khalid A. Hanafy
  • 通讯作者:
    Khalid A. Hanafy

Khalid A. Hanafy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Khalid A. Hanafy', 18)}}的其他基金

Modulation of the TLR4-Lyn interaction in SAH
SAH 中 TLR4-Lyn 相互作用的调节
  • 批准号:
    10529343
  • 财政年份:
    2021
  • 资助金额:
    $ 36.18万
  • 项目类别:
Modulation of the TLR4-Lyn interaction in SAH
SAH 中 TLR4-Lyn 相互作用的调节
  • 批准号:
    10348220
  • 财政年份:
    2021
  • 资助金额:
    $ 36.18万
  • 项目类别:
Human Cerebrospinal Fluid Macrophages and Outcome in Subarachnoid Hemorrhage
人脑脊液巨噬细胞和蛛网膜下腔出血的结果
  • 批准号:
    10372925
  • 财政年份:
    2021
  • 资助金额:
    $ 36.18万
  • 项目类别:
Modulation of the TLR4-Lyn interaction in SAH
SAH 中 TLR4-Lyn 相互作用的调节
  • 批准号:
    10274359
  • 财政年份:
    2020
  • 资助金额:
    $ 36.18万
  • 项目类别:
The role of TLR4-dependent sterile inflammation in mediating adverse outcomes after SAH
TLR4依赖性无菌炎症在介导SAH后不良后果中的作用
  • 批准号:
    9504669
  • 财政年份:
    2017
  • 资助金额:
    $ 36.18万
  • 项目类别:
The role of TLR4-dependent sterile inflammation in mediating adverse outcomes after SAH
TLR4依赖性无菌炎症在介导SAH后不良后果中的作用
  • 批准号:
    9386587
  • 财政年份:
    2017
  • 资助金额:
    $ 36.18万
  • 项目类别:
Microglial Signal Transduction in Fever and Vasospasm after Subarachnoid Hemorrha
蛛网膜下腔出血后发热和血管痉挛中的小胶质细胞信号转导
  • 批准号:
    8868189
  • 财政年份:
    2012
  • 资助金额:
    $ 36.18万
  • 项目类别:
Microglial Signal Transduction in Fever and Vasospasm after Subarachnoid Hemorrha
蛛网膜下腔出血后发热和血管痉挛中的小胶质细胞信号转导
  • 批准号:
    8437024
  • 财政年份:
    2012
  • 资助金额:
    $ 36.18万
  • 项目类别:
Microglial Signal Transduction in Fever and Vasospasm after Subarachnoid Hemorrha
蛛网膜下腔出血后发热和血管痉挛中的小胶质细胞信号转导
  • 批准号:
    8551758
  • 财政年份:
    2012
  • 资助金额:
    $ 36.18万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 36.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了